OCX News and Press, Oncocyte Corporation From 11/09/23

2023-11-09 09:36:06 ET OncoCyte Corporation (OCX) Q3 2023 Earnings Conference Call November 9, 2023, 8:00 am ET Company Participants Stephanie Prince - IR, PCG Advisory Josh Riggs - President & CEO Conference Call Participants Mike Matson - Needham ...

2023-11-09 07:27:36 ET More on OncoCyte Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Financial information for OncoCyte For further details see: OncoCyte GAAP EPS of -$0.81 beats by $0.20, revenue of $0.43M beats b...

-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for ...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Oncocyte Corporation (OCX) is expected to report $-1.52 for Q3 2023

2023-11-08 11:57:02 ET More on OncoCyte Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte Financial information for OncoCyte For further details see: OncoCyte Q3 2023 Earnings Preview

IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will host a conference call and webcast on Thursday, November 9, 2023, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discus...

Interventional study compares VitaGraft to current transplant rejection monitoring protocols Oncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than commonly used monitoring protocols (p<0.001) IRVINE, CA / ACCESSWIRE / September 18, 2023 / O...

CEO Josh Riggs will be meeting with registered investors on September 11-12, 2023 IRVINE, CA / ACCESSWIRE / September 6, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it will participate in the upcoming H.C. Wainwright 25th Annual Global Inve...

First digital-droplet PCR assay to receive coverage Expect initial revenue generation in Q1 2024 IRVINE, CA / ACCESSWIRE / August 28, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor ...